Court approves $7.25 billion Bayer settlement for Roundup cancer claims

Bayer agrees to $7.25 billion settlement with cancer patients over Roundup weedkiller claims.

6 cards · 1m 10s · tap to begin

From · · 1m 10s

Court approves $7.25 billion Bayer settlement for Roundup cancer claims

Bayer agrees to $7.25 billion settlement with cancer patients over Roundup weedkiller claims.

In brief

Bayer agrees to $7.25 billion settlement with cancer patients over Roundup weedkiller claims. Bayer will pay up to $7.25 billion to resolve cancer claims from Roundup users, including those with non-Hodgkin lymphoma. Originally reported by Seattletimes.

Court approves $7.25 billion settlement

Bayer will pay up to $7.25 billion over two decades to resolve thousands of cancer claims from U.S. patients.

Settlement covers current and future lymphoma cases

Participants could receive $10,000 to $165,000 based on product use, age at diagnosis, and illness severity.

Bayer denies Roundup causes cancer

Bayer claims Roundup does not cause cancer and faces mounting litigation costs.

Supreme Court ruling impacts lawsuits

U.S. Supreme Court ruled Bayer cannot be sued in state courts for failing to warn about cancer risks.

Average payouts deemed fair by judge

St. Louis Circuit Judge Timothy Boyer called average payouts 'fair and adequate' and the total 'among the largest in mass tort history'.

Bayer's strategy to mitigate risks

Bayer CEO Bill Anderson stated the settlement is a 'decisive milestone' in reducing Roundup litigation risks.

In short

Bayer will pay up to $7.25 billion to resolve cancer claims from Roundup users, including those with non-Hodgkin lymphoma.

Read the original on Seattletimes

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on bayer and related topics.